Precision Medicine and Diversity in PD: Lessons from the GEoPD and the path ahead
Join us in 2025 in Tuebingen as we mark the 20th anniversary of the Genetic Epidemiology of Parkinson’s disease (GEoPD). We will discuss how individualized strategies can embrace patient variability and drive more effective treatments.
For two decades, GEoPD’s global outreach has united clinicians, geneticists, data scientists, and other experts across 60 sites in 30 countries. This inclusive network fosters open collaboration, sharing region-specific insights and expanding our collective ability to identify genetic variations and novel therapeutic targets. Everyone’s contribution strengthens the mission to transform PD care.
Over the years, our decentralized and democratic model has safeguarded continuity and nurtured fresh leadership. Building on a shared repository of 41,988 PD cases and 41,505 control subjects, we have created a robust infrastructure for research breakthroughs. Key achievements include:
- Establishing standardized protocols and data-sharing practices
- Accelerating discovery of genetic risk factors and biomarkers
- Fostering a global community of dedicated PD researchers
Program Highlights
Eight sessions will cover different aspects of PD:
- Genomics and Epidemiology
- Biomarkers and PD
- Deep Brain Stimulation and PD
- Mechanisms and Therapeutics
- GEoPD and Diversity
- Patient’s World vs. Scientific World: Hope, Challenges, and the Path Ahead
- Data Blitz / GEoPD Outreach
- PD Funding and Patients: Converging Interests or Widening Gaps?
Global Perspectives and Participation
- Renowned experts from the United States, Germany, South Korea, Nigeria, Tanzania, Egypt, and France have already confirmed their participation.
- We anticipate delegates from more than 15 countries, creating a truly diverse forum for exchanging knowledge and best practices.
We truly appreciate your support in advancing PD research outreach and developing more effective treatment strategies.
Endorsement and Sponsors
